PKOH(PKOH)
PKOH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.72B | $1.78B | $1.87B |
| Low | $1.71B | $1.77B | $1.85B |
| High | $1.73B | $1.79B | $1.89B |
| EBITDA Avg | $137M | $145M | $159M |
| Low | $136M | $144M | $158M |
| High | $138M | $147M | $159M |
| EBIT Avg | $104M | $112M | $125M |
| Low | $103M | $111M | $124M |
| High | $105M | $113M | $125M |
| Net Income Avg | $45M | $52M | $62M |
| Low | $45M | $51M | $61M |
| High | $46M | $53M | $62M |
| EPS Avg | $3.26 | $3.68 | $4.40 |
| Low | $3.20 | $3.62 | $4.38 |
| High | $3.29 | $3.76 | $4.42 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $432M | $422M | $437M | $461M | $453M | $433M | $464M | $490M |
| Low | $431M | $419M | $435M | $459M | $451M | $431M | $461M | $488M |
| High | $433M | $424M | $439M | $463M | $454M | $435M | $466M | $492M |
| EBITDA Avg | $37M | $35M | $35M | $39M | $39M | $36M | $39M | $43M |
| Low | $36M | $34M | $35M | $39M | $39M | $36M | $39M | $43M |
| High | $37M | $35M | $35M | $39M | $39M | $36M | $40M | $44M |
| EBIT Avg | $29M | $27M | $27M | $31M | $30M | $28M | $31M | $35M |
| Low | $28M | $26M | $27M | $31M | $30M | $28M | $31M | $35M |
| High | $29M | $27M | $27M | $31M | $30M | $28M | $31M | $35M |
| Net Income Avg | $13M | $11M | $11M | $15M | $14M | $12M | $15M | $18M |
| Low | $12M | $11M | $11M | $15M | $14M | $12M | $15M | $18M |
| High | $13M | $12M | $12M | $15M | $14M | $12M | $15M | $18M |
| EPS Avg | $0.90 | $0.78 | $0.81 | $1.03 | $0.99 | $0.86 | $1.03 | $1.25 |
| Low | $0.87 | $0.75 | $0.80 | $1.02 | $0.98 | $0.85 | $1.02 | $1.24 |
| High | $0.92 | $0.81 | $0.81 | $1.04 | $1.00 | $0.86 | $1.04 | $1.26 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |